Appl Environ Microbiol 1981, 42:1018–1022.PubMed 9. Glasby C, Hatheway CL: Fluorescent-antibody reagents for the identification of Clostridium botulinum. J Clin Microbiol 1983, 18:1378–1383.PubMed 10. Bhandari M, Campbell KD, Collins MD, LGX818 chemical structure East AK: Molecular characterization of the clusters of genes encoding the botulinum neurotoxin complex in clostridium botulinum (Clostridium argentinense) type G and nonproteolytic Clostridium botulinum type B. Curr Microbiol 1997, 35:207–214.PubMedCrossRef 11. Raffestin S, Marvaud J,

Cerrato R, Dupuy B, Popoff M: Organization and regulation of the neurotoxin genes in Clostridium botulinum and Clostridium tetani. Anaerobe 2004, 10:93–100.PubMedCrossRef 12. Sharma SK, Singh BR: Hemagglutinin binding mediated protection of botulinum neurotoxin from proteolysis. J Nat Toxins 1998, 7:239–253.PubMed 13. Schiavo G, Malizio C, Trimble selleck kinase inhibitor WS, de Laureto PP, Milan G, Sugiyama H, Johnson EA, Montecucco C: Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond.

J Biol Chem 1994, 269:20213–20216.PubMed 14. Sonnabend WF, Sonnabend UP, Krech T: Isolation of Clostridium botulinum type G from Swiss soil specimens by using sequential steps in an identification scheme. Appl Environ Microbiol 1987, 53:1880–1884.PubMed 15. Ciccarelli AS, Whaley DN, McCroskey LM, Gimenez DF, Dowell VR, Hatheway CL: Cultural and physiological characteristics of Clostridium botulinum type G and the susceptibility of certain animals to its toxin. Appl Environ Microbiol 1977, 34:843–848.PubMed 16. Eklund MW, Poysky FT, Mseitif LM, Strom MS: Evidence for plasmid-mediated toxin and bacteriocin production in Clostridium botulinum type G. Appl Environ Microbiol 1988, 54:1405–1408.PubMed 17. Zhou Y, Sugiyama H, Nakano H, Johnson EA: The genes for the Clostridium botulinum type G toxin complex are on a plasmid. Infect Immun 1995, 63:2087–2091.PubMed 18. Hines H, Lebeda F, Cyclin-dependent kinase 3 Hale M, Brueggemann

E: Characterization of botulinum progenitor toxins by mass spectrometry. Appl Environ Microbiol 2005, 71:4478–4486.PubMedCrossRef 19. Boyer AE, Moura H, Woolfitt AR, Kalb SR, McWilliams LG, Pavlopoulos A, Schmidt JG, Ashley DL, Barr JR: From the mouse to the mass spectrometer: detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry. Anal Chem 2005, 77:3916–3924.PubMedCrossRef 20. Deery MJ, Maywood ES, Chesham JE, Sladek M, Karp NA, Green EW, Charles PD, Reddy AB, Kyriacou CP, Lilley KS, et al.: see more Proteomic analysis reveals the role of synaptic vesicle cycling in sustaining the suprachiasmatic circadian clock. Curr Biol 2009, 19:2031–2036.PubMedCrossRef 21. Welham NV, Marriott G, Tateya I, Bless DM: Proteomic changes in rat thyroarytenoid muscle induced by botulinum neurotoxin injection. Proteomics 2008, 8:1933–1944.PubMedCrossRef 22.